Antibiotics in Salmon Farming: A Controversial Necessity or a Hidden Risk?
A recent revelation has sparked concern among Tasmanians: Huon Aquaculture, a prominent salmon farming company, has confirmed the use of antibiotics in its hatchery on the River Derwent. This disclosure comes after the company treated diseased salmon with oxytetracycline, an antibiotic commonly used in agriculture and aquaculture, as well as in human medicine.
But here's where it gets controversial: while coastal marine fish farms have strict regulations around the use of the antibiotic florfenicol, there are no such requirements for freshwater facilities. This lack of transparency has raised eyebrows, especially considering the potential impact on public health and the environment.
The Tasmanian Inquirer's investigation brought this issue to light, revealing that Huon Aquaculture used antibiotics at its Meadowbank hatchery due to an increase in salmon mortality caused by an intestinal infection. The company's general manager, Depha Miedecke, explained that the warm water temperatures in mid-January led to this bacterial outbreak.
And this is the part most people miss: despite the voluntary disclosure to the Environment Protection Authority (EPA), downstream users were not informed. Ms. Miedecke defended the company's decision, stating that antibiotic use in freshwater is rare and not a regular practice. However, the EPA's subsequent implementation of antibiotic residue monitoring raises questions about the potential risks.
The World Health Organization (WHO) classifies oxytetracycline as a highly important antimicrobial, but also warns about the dangers of antimicrobial resistance due to misuse and overuse. Independent politician Meg Webb argues that the public shouldn't rely on voluntary disclosures and calls for full transparency. She believes that expert oversight and community awareness are crucial for building public confidence in the industry.
Interestingly, Huon Aquaculture previously used oxytetracycline during a mass mortality event in coastal salmon pens but found it largely ineffective. The industry has since been granted approval to use florfenicol, which has lower dosage requirements and toxicity levels. Real-time updates on florfenicol use are now available on salmon companies' websites.
The debate intensifies as the Greens demand real-time disclosures for all antibiotic use in Tasmanian waters, while Health Minister Bridget Archer assures the public that antibiotic use is heavily regulated in agriculture and aquaculture. Archer claims there are no public health risks, but the question remains: is the current regulatory framework sufficient to protect both the environment and public health?
